全文获取类型
收费全文 | 1597篇 |
免费 | 98篇 |
国内免费 | 7篇 |
专业分类
耳鼻咽喉 | 15篇 |
儿科学 | 26篇 |
妇产科学 | 23篇 |
基础医学 | 123篇 |
口腔科学 | 42篇 |
临床医学 | 163篇 |
内科学 | 411篇 |
皮肤病学 | 37篇 |
神经病学 | 123篇 |
特种医学 | 32篇 |
外科学 | 319篇 |
综合类 | 29篇 |
一般理论 | 2篇 |
预防医学 | 100篇 |
眼科学 | 59篇 |
药学 | 109篇 |
中国医学 | 19篇 |
肿瘤学 | 70篇 |
出版年
2023年 | 27篇 |
2022年 | 15篇 |
2021年 | 80篇 |
2020年 | 47篇 |
2019年 | 70篇 |
2018年 | 80篇 |
2017年 | 47篇 |
2016年 | 71篇 |
2015年 | 50篇 |
2014年 | 61篇 |
2013年 | 93篇 |
2012年 | 123篇 |
2011年 | 134篇 |
2010年 | 59篇 |
2009年 | 48篇 |
2008年 | 113篇 |
2007年 | 106篇 |
2006年 | 76篇 |
2005年 | 76篇 |
2004年 | 66篇 |
2003年 | 50篇 |
2002年 | 43篇 |
2001年 | 9篇 |
2000年 | 10篇 |
1999年 | 11篇 |
1998年 | 7篇 |
1997年 | 3篇 |
1996年 | 6篇 |
1995年 | 4篇 |
1993年 | 2篇 |
1992年 | 5篇 |
1991年 | 6篇 |
1990年 | 6篇 |
1989年 | 3篇 |
1988年 | 8篇 |
1987年 | 9篇 |
1986年 | 13篇 |
1985年 | 6篇 |
1984年 | 9篇 |
1983年 | 6篇 |
1982年 | 4篇 |
1981年 | 3篇 |
1978年 | 4篇 |
1974年 | 5篇 |
1969年 | 3篇 |
1967年 | 3篇 |
1966年 | 10篇 |
1965年 | 3篇 |
1946年 | 1篇 |
1945年 | 1篇 |
排序方式: 共有1702条查询结果,搜索用时 31 毫秒
1.
Mandar Jog Jack Lee Astrid Scheschonka Robert Chen Farooq Ismail Chris Boulias Douglas Hobson David King Michael Althaus Olivier Simon Hanna Dersch Steven Frucht David M. Simpson 《Toxins》2020,12(12)
In this first, double-blind, randomized, placebo-controlled exploratory trial, we evaluate the efficacy and safety of incobotulinumtoxinA and feasibility of using kinematic tremor assessment to aid in the planning of muscle selection in a multicenter setting. Reproducibility of the planning technology to other clinical sites was explored. In this trial (), patients with upper-limb essential tremor (ET) were randomized 2:1 to a single treatment cycle of incobotulinumtoxinA or placebo. A tremor kinematic analytics investigational device was used to define a customized muscle set for injection, related to the pattern of the wrist, forearm, elbow, and shoulder tremor for each patient, and the incobotulinumtoxinA dose per muscle (total ≤ 200 U). Fahn–Tolosa–Marin (FTM) Part B motor performance score, Global Impression of Change Scale (GICS), and kinematic analysis-based efficacy evaluations were assessed. Thirty patients were randomized (incobotulinumtoxinA, n = 19; placebo, n = 11). FTM motor performance scores showed greater improvement with incobotulinumtoxinA versus placebo at Week 4 (p = 0.003) and Week 8 (p = 0.031). The physician-rated GICS score indicated improvement with incobotulinumtoxinA versus placebo at Week 4 (p < 0.05). IncobotulinumtoxinA also decreased accelerometric hand-tremor amplitude versus placebo from baseline to Week 4 (p = 0.004) and Week 8 (p < 0.001), with persistent tremor reduction up to 24 weeks post-injection. IncobotulinumtoxinA produced a slight and transient reduction of maximal grip strength versus placebo; two patients reported localized finger muscle weakness. Customized incobotulinumtoxinA injections decreased tremor severity and improved hand motor function in patients with upper-limb ET after a single injection cycle, with a favorable tolerability profile. The study showed that tremor kinematic analytics technology could be successfully scaled for use in other clinical sites. NCT02207946相似文献
2.
3.
Expression of TRIM22 mRNA in chronic hepatitis C patients treated with direct-acting antiviral drugs
Mariam Naveed Amjad Ali Nadeem Sheikh Shazia Rafique Muhammad Idrees 《APMIS : acta pathologica, microbiologica, et immunologica Scandinavica》2020,128(4):326-334
Hepatitis C is a global public health problem, and Pakistan is the second largest country in the globe with highest prevalence rate of hepatitis C virus (HCV). Until 2014, pegylated interferon (PEG-IFN) plus ribavirin (RBV) has been the standard therapy for HCV, however, owing to its adverse side effects and very low sustained virologic response (SVR) rates therapeutics trend is shifted toward direct-acting antivirals. Tripartite motif containing 22 (TRIM22) is a dynamic antiviral protein that can inhibit multiple viruses in vivo. Expression of TRIM22 mRNA has been linked to outcome of PEG-IFN and ribavirin therapy, where its higher expression leads to rapid virus clearance. However, in terms of therapy with direct-acting antiviral (DAA) or double DAA, impact of TRIM22 expression is largely unknown. These new drugs show more than 90% of SVR rates and lesser side effects and have proven to be better than IFN therapy. Endogenous IFN system suppresses various pathogens through the induction of antiviral effectors termed as interferon-stimulating genes (ISGs). We have studied the expression levels of one of these antiviral effectors, TRIM22 in response to sofosbuvir (SOF) and daclatasvir (DAC) in combination with RBV, using quantitative PCR in the peripheral blood mononuclear cells (PBMCs) of HCV-infected patients. We have observed sustained virus clearance in more than 90% of patients treated with DAA and double DAA and have seen the expression of TRIM22 to be higher in patients who attained SVR as compared to the untreated patients. We have also observed downregulation of TRIM22 in patients who failed to attain rapid virus clearance, and upregulation in those who achieved rapid clearance of virus. Genetic factors that determine the lower TRIM22 expression in these patients are needed to be explored that may also play a role in lower response to anti-HCV therapy. Endogenous IFN system and effects of antiviral proteins in response to DAA therapy is needed to be studied in order to better understand the host response toward these drugs to make them more effective. 相似文献
4.
Amrallah A. Mohammed Abdullah S. Al-Zahrani Mian U. Farooq Hafez M. Ghanem Lobna A. Abdelaziz Hani M. EL-Khatib 《Indian journal of hematology & blood transfusion》2015,31(4):439-445
Venous thromboembolism (VTE) represents one of the most important causes of morbidity and mortality in cancer patients. This investigation was undertaken to investigate the natural history of VTE in the oncology center in a tertiary care hospital. We did a retrospective study on cancer patients who presented to King Abdullah Medical city in Holly capital; a tertiary care hospital; from May 2011 to June 2013. Follow up period was calculated from time of VTE diagnosis till the last clinical visit or till patient death. Among 1,678 cancer patients, 132 (7.87 %) were diagnosed with VTE. The median patient age was 53.5 years, with female to male ratio 1.3/1. Thirty one patients (23.5 %) were diagnosed with VTE and cancer simultaneously, seventy four patients (56.1 %) were on chemotherapy and twenty eight patients (21.2 %) were on best supportive care.VTE were symptomatic in 110 patients (83.3 %) and asymptomatic in 22 patients (16.7 %). Lower limbs were the commonest site (42.4 %) with the highest incidence in patients with advanced stages (93 %). Forty nine (37 %) patients were receiving LMWH as prophylaxis. Median survival in months for patients with VTE prophylaxis versus without prophylactic, and asymptomatic versus symptomatic were (12.6 vs 6.3; p 0.12 and 9.8 vs 12.4; p 0.885, respectively). There is underutilization of thromboprophylaxis in our region, which needs more effort to reduce VTE burden. Also we need large prospective studies to clarify the impact of VTE symptoms and presentation on patient’s survival. 相似文献
5.
Luke Witherspoon Sean O'Reilly Jeremiah Hadwen Nafisa Tasnim Alex MacKenzie Faraz Farooq 《CTS Clinical and Translational Science》2015,8(4):298-304
Myotonic dystrophy type 1 (DM1) is caused by an expanded trinucleotide (CTG)n tract in the 3′ untranslated region (UTR) of the dystrophia myotonica protein kinase (DMPK) gene. This results in the aggregation of an expanded mRNA forming toxic intranuclear foci which sequester splicing factors. We believe down‐regulation of DMPK mRNA represents a potential, and as yet unexplored, DM1 therapeutic avenue. Consequently, a computational screen for agents which down‐regulate DMPK mRNA was undertaken, unexpectedly identifying the sodium channel blockers mexiletine, prilocaine, procainamide, and sparteine as effective suppressors of DMPK mRNA. Analysis of DMPK mRNA in C2C12 myoblasts following treatment with these agents revealed a reduction in the mRNA levels. In vivo analysis of CD1 mice also showed DMPK mRNA and protein down‐regulation. The role of DMPK mRNA suppression in the documented efficacy of this class of compounds in DM1 is worthy of further investigation. 相似文献
6.
Sabba Mehmood M.Phil. Sayed Hajan Shah M.Phil. Abid Jan M.Phil. Muhammad Younus M.Phil. Farooq Ahmad M.Phil. Muhammad Ayub M.Phil. Wasim Ahmad Ph.D. 《Pediatric dermatology》2016,33(1):e40-e42
Hypotrichosis is a condition of abnormal hair pattern characterized by sparse to absent hair on different parts of the body, including the scalp. The condition is often characterized by tightly curled woolly hairs, discoloration of hair, and development of multiple keratin filled cysts or papules on the body. Sequence analysis of the lipase H (LIPH) gene, mapped on chromosome 3q27.3, led to the identification of a novel frameshift deletion variant (c.932delC, p.Pro311Leufs*3) in one family and previously reported 2‐bp deletion (c.659_660delTA) in five other families, inherited hypotrichosis, and woolly hair in an autosomal recessive pattern. The study further extends the body of evidence that sequence variants in the LIPH gene result in hypotrichosis and woolly hair phenotype. 相似文献
7.
Muhammad Amjad Khan M.Sc. F.R.C.P.C.H. Lindsay Shaw F.R.C.P. F.R.C.P.C.H. Despina Eleftheriou Ph.D. M.R.C.P.C.H. Prab Prabhakar F.R.C.P.C.H. Wui K. Chong M.D. F.R.C.R. Mary Glover M.A. F.R.C.P. F.R.C.P.C.H. 《Pediatric dermatology》2016,33(2):e95-e98
We report the case of a young girl who presented with hemiparesis, seizures, and subtle features consistent with a linear form of facial morphea (en coup de sabre). She was treated with pulsed parenteral steroids and oral steroids and started on methotrexate. Magnetic resonance imaging results and neurologic problems improved after 6 months. Switching off inflammation early in the course of disease seemed to reverse some of the central nervous system changes. Assessment of children with unexplained hemiparesis and seizures should include careful examination of the face and scalp, looking for subtle signs of skin change and asymmetry. This is one of the few reported cases of neuroradiologic improvement after immunosuppressive treatment in a child with en coup de sabre. 相似文献
8.
Jay W. Rhee Rory J. Petteys Amjad N. Anaizi Faheem A. Sandhu Jean-Marc Voyadzis 《European spine journal》2015,24(11):2546-2554
9.
Nicotine and lipopolysaccharide affect cytokine expression from gingival fibroblasts 总被引:2,自引:0,他引:2
BACKGROUND: This in vitro study investigated the influence of nicotine, lipopolysaccharide (LPS), and a combination of both agents on cytokine expression from human gingival fibroblasts (HGFs). METHODS: HGFs were exposed for 48 hours to 250 microg/ml nicotine, 1 microg/ml Porphyromonas gingivalis LPS, or both. The expression of multiple cytokines was detected in the HGFs conditioned media using cytokine protein arrays. RESULTS: The untreated HGFs expressed several cytokines, which included relatively high levels of interleukin (IL)-6, IL-8, and monocyte chemoattractant protein-1 (MCP-1). They also expressed low levels of growth-regulated oncogene (GRO), IL-3, and IL-10. Nicotine had the greatest effect on the expression of GRO-alpha, IL-7, IL-10, and IL-15 compared to the untreated control. P. gingivalis LPS had the greatest effect on the expression of GRO-alpha; IL-7; IL-10; and RANTES (regulated on activation, normal T-cell expressed, and presumably secreted) compared to the untreated control. The combination of both agents had the biggest impact on the expression of GRO-alpha, IL-7, IL-10, IL-15, RANTES, and interferon-gamma (IFN-gamma) compared to the untreated control. CONCLUSION: HGFs exposed to nicotine, P. gingivalis LPS, or a combination of both agents increased the expression of multiple cytokines. 相似文献
10.
Tahir Yaqub Muhammad Nawaz Muhammad Z. Shabbir Muhammad A. Ali Imran Altaf Sohail Raza Muhammad A. B. Shabbir Muhammad A. Ashraf Syed Z. Aziz Sohail Q. Cheema Muhammad B. Shah Saira Rafique Sohail Hassan Nageen Sardar Adnan Mehmood Muhammad W. Aziz Sehar Fazal Nadir Hussain Muhammad T. Khan Muhammad M. Atique Ali Asif Muhammad Anwar Nabeel A. Awan Muhammad U. Younis Muhammad A. Bhattee Zarfishan Tahir Nadia Mukhtar Huda Sarwar Maaz S. Rana Omair Farooq 《Biomedical and environmental sciences : BES》2021,34(9):729-733
In 2019, the newly emerged SARS-CoV-2 virus caused pneumonia-like illness. The disease rapidly spread globally, leading to a worldwide outbreak referred to as the COVID-19 pandemic. The affected patients show symptoms of fever, dry cough, respiratory distress, myalgia, and gastrointestinal disturbance. As of April 5, 2021, 132,083,022 people worldwide were affected by COVID-19, while 2,868,454 people died due to the disease[1]. SARS-CoV-2-positive patients may remain asymptomatic or start showing symptoms in 2?14 days after exposure to the virus[2]. The viral infection can be diagnosed from nasopharyngeal, throat, alveolar lavage, lacrimal, blood, and stool samples. The patient starts shedding the virus in stool regardless of being symptomatic or asymptomatic, which makes sewage-based detection of the virus to be more beneficial in the early infection stage. 相似文献